FDA Approval Activities for this Drug
Synarel (nafarelin acetate) 200 mcg nasal solution, only Searle NDA 19-886/S-013 12/24/98 12/29/98 7/21/99
Synarel Indication:provides for revisions to the CLINICAL PHARMACOLOGY and ADVERSE REACTIONS sections of the labeling (endometriosis) | SYNAREL (nafarelin acetate) Nasal Spray Solution, Pfizer, Labeling Revision